Sreeya Pharma: Pioneering a new era of API & Bulk Drug Production in Karnataka

Sreeya Pharma Private Limited's venture into the API & Bulk Drug manufacturing sector in Kadechur, Karnataka, represents a strategic expansion to meet the burgeoning demand for pharmaceutical components in India. With a project cost of ₹35 crores spread over 2 acres, this initiative aims to bolster the nation's pharmaceutical self-sufficiency.

The forthcoming unit will specialize in the production of various APIs and bulk drugs vital for pharmaceutical formulations, although specific product details and production capacities remain undisclosed at this stage. This manufacturing diversity is poised to cater to a wide spectrum of pharmaceutical needs.

While details regarding the technology to be deployed in the manufacturing process are yet to be unveiled, the project holds promise in terms of enhancing production efficiency and adhering to quality standards.

Beyond its economic implications, the project holds the potential to foster regional development by generating employment opportunities throughout its construction and operational phases. This infusion of employment is expected to have a positive socio-economic impact on the Kadechur locality and its surrounding areas.

As the project progresses, Sreeya Pharma Private Limited's foray into API & Bulk Drug manufacturing is anticipated to reinforce India's position as a global pharmaceutical hub while creating a ripple effect of economic growth and industrial advancement in the region.

News by Rahul Yelligetti